Business Description
Kintara Therapeutics is a biopharmaceutical company focused on the development and commercialization of new solid tumor cancer therapies.
REM-001 Therapy consists of three parts, a laser light source, a light delivery device and the drug REM-001 (collectively, REM-001 Therapy). REM-001 is a second generation photosensitizer drug that has undergone late stage clinical development, and which we believe possesses multiple advantages over earlier generation PDT compounds. Our lead indication for REM-001 Therapy is unresectable cutaneous metastatic breast cancer (CMBC), a disease that may affect individuals with advanced breast cancer and for which effective treatment options are limited. For this and similar cutaneous applications, the light delivery device is a simple and easy to use fiber optic wand that the physician employs to directly illuminate the tumor with light.
Company Info
Address:
9920 Pacific Heights Blvd, Suite 150
San Diego, CA 92121
United States
Telephone:
858-350-4364
Email:
info@kintara.com
Industry Classifications
Sector:
Healthcare
Industry:
Pharmaceuticals
NAICS:
HMO Medical Centers (621491)
SIC:
Hospital And Medical Service Plans (6324)